INS and Hyperglycemia: Prior studies on STZ-induced rat models show that the 65 mg/kg dose achieves substantial β-cell destruction (about 84% reduction in pancreatic insulin content within 24 h), leading to long-lasting hyperglycemia and a stable T1DM phenotype without excessive mortality [30].